Prolistem® intends to replace conventional infertility treatments that are currently given to azoospermia men as default due to the lack of other choices
The road to the FIFA World Cup starts with preparation—and for men with non-obstructive azoospermia, Prolistem® is the preparation that may help improve MicroTESE success. 🌍 #WorldCup2026#Prolistem#Azoospermia#MicroTESE
Prolistem is only part of the strategy. Monthly semen analysis during and after treatment is essential, as sperm production may be intermittent. Finding sperm at the right time can make all the difference.
What is the success rate of Prolistem for azoospermia?
This is one of the most important questions patients ask.
Azoospermia is a complex condition, and no treatment can guarantee results. However, Prolistem was designed to give men with non-obstructive azoospermia a new chance
Prolistem was born from the science of spermatogenesis, specifically engineered to address the complex biological hurdles of non-obstructive azoospermia
When is the best time for micro-TESE after Prolistem?
The optimal window is 1–2 months after finishing the 6-month course, with 1 month being the "sweet spot" for peak sperm maturation.
PRO-TIP: Get frequent semen analysis during the 6 months!
From Maturation Arrest to Detectable Sperm in Semen — A Promising Breakthrough
A patient diagnosed with maturation arrest based on FNA. After six months of Prolistem use 100,000 sperm per mL, with a total of 500,000 sperm per sample.
2025 was a year full of hope and success for the Prolistem community.
Many of these real patient stories are shared on our website and social media.
Prolistem was developed to support men with non-obstructive azoospermia using a science-based and thoughtful approach.
Prolistem® Success Story
A patient diagnosed with azoospermia showed zero sperm on initial semen analysis. After Prolistem® treatment, sperm were detected in the semen within five months, reaching 1.5 million sperm.
Proud to present the clinical use of Prolistem® in non-obstructive azoospermia, discussed by leading experts from Istanbul University at the Turkish Association of Urology.
Advancing science into real clinical solutions for male infertility.
We turn science into treatment.
By understanding how sperm production truly works, we developed Prolistem®—a targeted approach designed for men with azoospermia.
we focus on improving the testicular environment itself.
Before undergoing microTESE, consider Prolistem
Prolistem Success Story
A patient with FSH 14, LH 7.9, and Testosterone 8
After completing Prolistem the first three months, a few thousand sperm were detected in his semen sample.
Dr. Faisal Al-Omar from Syria at the Middle East Fertility Conference 2025 in Dubai.
Dr. Faisal expressed his happiness with the results of Prolistem, noting that the outcomes were unexpected and the success cases were very encouraging.
It was an exciting and inspiring experience at MEFS 2025 in Dubai.
Events like these are essential for staying updated with the latest knowledge, innovations, and achievements in both male and female fertility.
Good morning from Day 2 at MEFS 2025 in Dubai!
Another busy day meeting doctors and specialists, raising awareness about Prolistem and its importance for men suffering from non-obstructive azoospermia.
Proud to share our work and help open new doors for patients.
Men with severe oligospermia who didn’t get results from traditional treatments are encouraged to consider the Prolistem 6-month course. Many users have seen improved outcomes, including natural pregnancy.
Not sure how to begin? We’re here to help and guide you step by step.